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Replication of prions is dependent on the presence 
of the host protein PrP c. During the course of dis- 
ease, PrP c is converted into an abnormal isoform, 
PrP s¢, which accumulates in the brain. Attempts to 
identify the cell type(s) in which prion replication 
and PrP conversion occur have reached conflicting 
results. Although PrP mRNA is present in high 
amounts in neurons throughout the life of the ani- 
mal, PrP sc initially accumulates in astrocytes and 
possibly other glial cells and, later in the course of 
the disease, spreads diffusely in the tissue, often 
in white matter. We report here that PrP mRNA is 
expressed not only in neurons but also in astrocytes 
and oligodendrocytes throughout the brain of post- 
natal hamsters and rats. The |evel of glial PrP mRNA 
expression in neonatal animals was comparable to 
that of neurons and increased two-fold during post- 
natal development. A substantial portion of brain 
PrP mRNA is therefore contributed by glial cells. 
Our results provide an explanation for the accumu- 
lation of PrP sc in white matter tissue and in the cyto- 
plasm of glial cells and argue for a direct involve- 
ment of glia in prion propagation. 
Introduction 
Transmissible spongiform encephalopathies (TSEs) com- 
prise a group of slow degenerative diseases of the CNS, 
characterized by gliosis, loss of neurons, and the forma- 
tion of amyloid plaques (Prusiner, 1987). The principal 
component of the amyloid is PrP sc (DeArmond et al., 1985), 
an abnormal isoform of the cellular prion protein (prpc; 
Oesch et al., 1985; Basler et al., 1986). PrP s° is the only 
macromolecule found to copurify with infectivity (Bolton 
et al., 1982; McKinley et al., 1983; Prusiner et al., 1984; 
Gabizon et al., 1988) and was therefore suggested to be 
sufficient for infection and pathogenesis (Prusiner, 1991). 
Propagation of the infectious agent apparently involves 
conversion of PrP c into PrP s~ (Prusiner et al., 1990; Pan 
et al., 1993). The cell type in which replication of prions 
occurs, however, is unknown. 
It has been postulated, from the results of X-irradiation 
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experiments in mice, that long-living lymphoreticular cells 
are responsible for initial propagation of infectivity after 
intraperitoneal injection (Fraser et al., 1989). Sequential 
infection with different strains of scrapie has led to the 
limited replication site hypothesis (Dickinson et al., 1972, 
1975; Kimberlin and Walker, 1985) suggesting that a sub- 
population of cells may be critical. Studies on the kinetics 
and pattern of PrP sc accumulation for various prion iso- 
lates led to the suggestion that different strains of prions 
replicate in different cells of the CNS (Hecker et al., 1992). 
Replication of prions depends on the expression of the 
PrP gene in the infected host cells, since mice devoid 
of PrP c fail to propagate infectivity (B0eler et al., 1993; 
Prusiner et al., 1993). Cell types expressing PrP are there- 
fore candidates for prion replication and TSE pathogene- 
sis. Neuronal PrP mRNA expression has been documented 
by in situ hybridization experiments (Kretzschmar et al., 
1986; Manson et al., 1992; Harris et al., 1993), yet 
astrocytes, and possibly other glial cells, accumulate PrP sc 
early in disease (Diedrich et al., 1991). At a later stage, 
white matter tracts such as the corpus callosum are 
strongly positive for PrP sc (Taraboulos et al., 1992). This 
may be the result of cortical neurons producing PrP sc and 
transporting it axonally, where it is taken up by astrocytes 
lying within the corpus callosum. Alternatively, PrP sc may 
be synthesized locally by glial cells. This, however, would 
require that they express PrP c. In this study, we have ex- 
amined PrP expression in various glial cell types at various 
developmental stages. By in situ hybridization and North- 
ern blot analysis, PrP mRNA was readily detectable in 
astrocytes and oligodendrocytes of young and adult 
animals. 
Our finding of glial PrP expression reconciles the crucial 
role of PrP c in prion replication with the following two ob- 
servations: PrP s~ accumulates in white matter and in the 
cytoplasm of glia (Taraboulos et al., 1992; Diedrich et al., 
1991), and the histopathology of TSEs suggested to many 
researchers that glial cells, in particularly astrocytes, are 
directly affected by the infectious agent (Eklund et al., 
1963; Pattison and Jones, 1967; Masters et al., 1984; Man- 
uelidis et al., 1987; Diedrich et al., 1991; Georgsson et 
al., 1993). We therefore suggest that prion diseases may 
have a glial origin. 
Results 
PrP Is Expressed in Glial Cells of the Corpus 
Callosum and the Optic Nerve 
The expression pattern of PrP in the hamster brain was 
studied at various postnatal developmental stages (post- 
natal day [P] 2, P10, P20, and adult). Sagittal brain cryo- 
sections were hybridized in situ with digoxigenin-labeled 
riboprobes specific for PrP mRNA or neuron-specific eno- 
lase (NSE) mRNA. Hybridization was performed in the 
presence of detergents to increase the permeability of 
white matter areas. Hybridized probes were visualized us- 










Figure 1. Expression of PrP mRNA at Various Postnatal Ages in the Corpus Callosum of Syrian Hamsters 
Serial sagittal brain cryosections of P2 (A and 13), P 10 (C and D), P20 (E, F, and I), and adult (G and H) animals were hybridized with digoxigenin-labeled 
cRNA probes specific for PrP mRNA (A, C, E, and G) or NSE mRNA (B, D, F, and H) or with digoxigenin-labeled PrP sense-riboprobe (I; negative 
control). PrP mFINA expression was evident not only in the neocortex (nc) and the hippocampus (hc) but also in the cells of the corpus callosurn 
(cc) in P2-P20 animals. The distribution of PrP mRNA is shown in comparison with that of NSE mRNA, which is strictly localized in neurons. A 
cresyl violet staining of adult tissue (J) serves as an overview of the brain areas and their cell densities. The box represents the area depicted in 
(G) and (H). Bar, 100 I~m (A-I), 400 I~m (J). 
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1 shows the corpus callosum surrounded by neocortex 
and the hippocampus. The distribution of PrP mRNA (Fig- 
ures 1A, 1C, 1 E, and 1G) was compared with that of NSE 
mRNA (Figures 1B, 1D, 1F, and 1H). PrP mRNAwas found 
not only in neuronal cell bodies in neocortex and the hippo- 
campus but also in glial cell bodies in fiber tracts like the 
corpus callosum. Glial cell staining was observed in brains 
of animals aged 2-20 days (Figures 1A, 1 C, and 1E). Dur- 
ing this developmental period, most cells in the corpus 
callosum (>90%) were labeled In contrast, no PrP tran- 
scripts could be detected in the corpus callosum of adult 
animals. This result at first indicated a down-regulation of 
PrP mRNA in white matter; however, from our Northern 
blot analyses shown below, it became clear that our failure 
to detect PrP mRNA in adult white matter was due to a 
reduced efficiency of the in situ ~ybridization procedure in 
this tissue. Control hybridizations with digoxigenin-labeled 
sense transcripts did not reveal any signal in the corpus 
callosum (Figure 11). 
PrP expression in glial cells was studied further in the 
optic nerve, a fiber tract that is well characterized in its 
postnatal development, especially in rats. During the first 
postnatal week, the majority of cells present in the rat optic 
nerve are astrocytes, most of which have undergone their 
final cell division (Vaughn, 1969; Skoff et al., 1976a, 
1976b; Skoff, 1990). Around the time of myelination (after 
P6), the percentage of oligodendrocytes increases rapidly, 
so that, at the age of 3 weeks, they constitute a clear 
majority of the cells (Vaughn, 1969; Skoff et al., 1976a, 
1976b). Microglia are present in small numbers (<5%) du r- 
ing postnatal development and adulthood (Foulcrand and 
Privat, 1977; Dentinger et al., 1985). Our experiments 
were carried out with both hamster and rat optic nerves 
to demonstrate that glial PrP expression is not a peculiarity 
of hamsters. PrP transcripts were detected in hamster op- 
tic nerves at P2 (Figure 2A), P5 (data not shown), P10 
(Figure 2B), and P20 (Figure 2C). PrP mRNA was also 
present in the rat optic nerve at P7 (data not shown) and 
hamster rat 
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Figure 2. Expression of PrP mRNA at Various Postnatal Ages in the Optic Nerve of Syrian Hamsters and Lewis Rats 
Optic nerves of hamsters (A-D) or rats (E-G) were prepared at the indicated evelopmental stages, sectioned longitudinally, and hybridized with 
riboprobes pecific for PrP (A-E and G) or MBP (F) mRNA. in (E) and (F), parallel sections are shown. PrP mRNA-specific signal was present 
in optic nerves of young but not adult animals. Note that the dark appearance of the adult optic nerve does not represent a specific hybridization 
signal but is due to the density of the myelinated tissue. Rostral is to the left. Bar, 100 p_m. 
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P14 (Figure 2E). The expression of PrP mRNA increased 
slightly in the hamster optic nerve between P2 and P20 
(Figures 2A-2C). By Northern analysis, an approximately 
two-fold increase in PrP mRNA was observed in rat optic 
nerve RNA between P2 and P14 (see Figure 4B, lanes 
1 and 2). No hybridization signal was obtained in adult 
hamster or rat optic nerves (Figures 2D and 2G, respec- 
tively). This was due to a reduced efficiency of the in situ 
hybridization procedure in adult white matter, as shown 
in the next paragraph. 
Adult Glial Cells Produce PrP 
The absence of an in situ hybridization signal for PrP 
mRNA in gila o! adult animals (Figure 1G; Figures 2D and 
2G) initially suggested a down-regulation of glial PrP mRNA 
expression. Since it is known that myelination causes a 
reduced sensitivity of the in situ hybridization technique 
(Schaeren-Wiemers and Gerfin-Moser, 1993), we ana- 
lYzed optic nerve RNA of young and adult rats for its con- 
tent of PrP mRNA using Northern blots. The level of PrP 
mRNA in adult optic nerve was similar to that at P14 (see 
Figure 4C, lanes 2 and 3), indicating that glial PrP mRNA 
expression had not changed in adulthood. PrP mRNA was 
also present in sciatic nerve (see Figure 4C, lane 4) at a 
level similar to that in optic nerve. This shows that PrP 
is expressed in fiber tracts of the central and peripheral 
nervous system of young and adult animals. 
Glial Cell Types Expressing PrP 
In the optic nerve, positive cell bodies were often aligned 
in rows parallel to nerve fibers, an arrangement hat is 
typical of oligodendrocytes (Figure 2). Cells positive for 
PrP mRNA were also detected in the region of the lamina 
cribrosa that represents the anterior part of the optic nerve 
near the retina-optic nerve junction (Figure 2E). This re- 
gion of the optic nerve remains unmyelinated uring the 
life of the animal and is devoid of oligodendrocytes and, 
presumably, of their precursor cells (Berliner, 1931 ; Hilde- 
brand et al., 1985; ffrench-Constant et al., 1988). It is there- 
fore characterized by the absence of myelin basic protein 
(MBP), a specific marker of oligodendrocytes, and its cor- 




Figure 3. Expression of PrP mRNA in Oligodendrocytes and Astrocytes of the Corpus Callosum of Syrian Hamster 
(A and B) A cryosection of a P20 brain was simultaneously h bridized with probes for PrP and PLP/DM-20 mFINA. Hybridized probes were first 
visualized for PrP (A, purple color) followed by PLP/DM-20 (B, brown color). Examples of double-positive c lls in the corpus callosum (cc) are 
marked by arrows. The arrowhead points to a cell positive only for PrP. 
(C-E) A section of a P10 brain was hybridized with probes for PrP mRNA (C), followed by immunofluorescence detection of GFAP (D) and Hoechst 
33258 staining of cell nuclei (E). All three panels show an identical region from the corpus callosum. Note that he color precipitate ofthe in situ 
hybridization signal quenches GFAP fluorescence, hc, hippocampus; nc, neocortex. Bar, 50 I~m. 
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region of the lamina cribrosa represent astrocytes or mi- 
croglial cells. As microglia constitute only 1%-5% of the 
cell population of the optic nerve throughout postnatal de- 
velopment and adulthood (Foulcrand and Privat, 1977; 
Dentinger et al., 1985), the majority of these PrP-expressing 
cells are astrocytes. To identify glial cell types positively, 
we did double-labeling experiments. 
Oligodendrocytes expressing PrP mRNA were identi- 
fied by their specific markers, proteolipid protein (PLP) 
and DM-20, a splice variant of PLP (Nave et al., 1987). A 
sagittal brain section of a P20 hamster was simultaneously 
probed with both PrP and PLPfDM-20 mRNA-specific ri- 
boprobes. Hybridization signats were first visualized for 
PrP (purple color precipitate, Figure 3A) and then for PLP/ 
DM-20 (brown color precipitate, Figure 3B); 60% of the 
PrP-positive cells of the corpus callosum were also posi- 
tive for PLP/DM-20. Double-positive cells indicate oligo- 
dendrocytes that express PrP mRNA, while cells negative 
for PLP/DM-20 may be immature oligodendrocytes, mi- 
croglia or astrocytes. 
Astrocytic PrP mRNA expression was evident from the 
ubiquitous presence of PrP transcripts in the cells of tis- 
sues that consisted almost exclusively of astrocytes, 
namely neonatal white matter tissue and the lamina cri- 
brosa region of the optic nerve (Figure 1A and Figures 
2A and 2E, respectively). The presence of PrP mRNA in 
astrocytes can also be demonstrated irectly by colocali- 
zation of PrP transcripts and glial fibrillary acidic protein 
(GFAP) within the same cell (Figures 3C-3E). Sagittal sec- 
tions of P10 hamster brains were subjected to in situ hy- 
bridization for PrP mRNA (Figure 3C), followed by im- 
munofluorescence detection of GFAP (Figure 3D) and 
staining of nuclei with Hoechs ~, 33258 dye (Figure 3E). A 
clear correlation of GFAP fibers to the respective cell nu- 
clei and the PrP mRNA signal is seen in astrocytes with 
processes extending in the plane of cutting (indicated by 
arrows in Figures 3C-3D). Much of the GFAP immunofluo- 
rescence was localized in extended processes and could 
not be correlated with the location of cell bodies. 
Our in situ hybridization studies documented rather uni- 
form labeling of the cells present in the optic nerve and the 
corpus callosum, irrespective of the relative proportions 
of different glial cell types at various ages. We chose to 
investigate further the level of oligodendrocytic and astro- 
cytic PrP mRNA expression in preparations of the respec- 
tive cell types. Oligodendrocytes were isolated from brain 
stem of 14- to 17-day-old rats. The enrichment for oligo- 
dendrocytes was revealed by a higher number of galacto- 
cerebroside-positive cells (data not shown) and an in- 
crease in PLP/DM-20 mRNA content (Figure 4A). Whereas 
the abundance of NSE and GFAP mRNA was decreased 
at least ten-fold as a result of the oligodendrocyte purifica- 
tion procedure, the PrP mRNA abundance was reduced 
only slightly (Figure 4A). This indicates that PrP transcripts 
are present in high amounts in oligodendrocytes of young 
animals. As no comparable purification procedure is avail- 
able for astrocytes, we enriched astrocytes in the optic 
nerve by X-irradiation (Colello et al., 1994). Neonatal rats 
were irradiated unilaterally at their heads at P0, P2, and 
P4. The resulting depletion of oligodendrocyte precursor 
cells leads to a delayed appearance of myelinating oligo- 
dendrocytes (Colello et al., 1994). At P14, the irradiated 
optic nerve is still devoid of oligodendrocytes, whereas 
the astrocytic cell population appears normal. Northern 
analysis of total RNA preparations from irradiated and 
nonirradiated optic nerves revealed the presence of PrP 
mRNA in both preparations in similar amounts (Figure 4B, 
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Figure 4. Northern Analysis of Rat Brain and 
Optic and Sciatic Nerve RNA 
(A) RNA of P14-P17 brain stem (lane 1) and of 
oligodendrocytes purified from the same tissue 
(lane 2) was analyzed for its content of PrP, 
NSE, GFAP, and PLP mRNA. The amount of 
PrP mRNA was similar in both preparations, 
whereas the nrichment for oligodendrocytes 
resulted in an increase of PLP mRNA and a 
decrease of NSE and GFAP mRNA. 
(B) RNA of normal (lanes 1 and 2) and Xoirra- 
diated optic nerve (lane 3) was isolated at P2 
(lane 1) and P14 (lanes 2 and 3) and analyzed 
for the content of PrP mRNA. The depletion 
of oligodendrocytes from the irradiated nerve 
(demonstrated by its marginal content of MBP 
mRNA; lane 3) did not affect the relative 
amount of PrP mRNA contained in total RNA. 
(C) RNA from adult brain (lane 1),P14 optic 
nerve (lane 2), adult optic nerve (lane 3), and 
adult sciatic nerve (lane 4) was analyzed for its 
content of PrP mRNA. PrP mRNA was present 
at equal levels inP 14 and adult optic nerve and 
sciatic nerve. 
Asterisks indicate the relative positions of the 
28S and the 18S RNA. In (B) and (C), the 
amounts of 28S RNA after electrophoresis are 




therefore not altered by irradiation, whereas the amount of 
MBP mRNA was reduced drastically (Figure 4B, bottom 
panel). These results demonstrate that PrP mRNA is ex- 
pressed in both astrocytes and oligodendrocytes, and that 
the level of expression is similar in both cell types. 
Discussion 
Prion Disease and Glial PrP Expression 
Infection of humans and animals by prions leads to repli- 
cation of the infectious particle, PrP so production, and 
pathologic changes in the central nervous system. The 
cell type(s) responsible for these events has not yet been 
identified. A prerequisite for prion replication and PrP sc 
production is the expression of PrP c (BOeler et al., 1993). 
Previously, PrP mRNA has been localized primarily in neu- 
rons (Kretzschmar et al., 1986; Manson et al., 1992; Harris 
et al., 1993), suggesting that they produce PrP s°, which 
would in turn be toxic for nerve cells. This simple model 
is contradicted, however, by several findings. The first ac- 
cumulations of PrP sc are found in glial cells, some of them 
colocalizing with cytoplasmic GFAP in astrocytes (Died- 
rich et al., 1991). These accumulations precede astro- 
cytosis and subsequent neuronal oss. In animals with clin- 
ical disease, major accumulations of PrP s~ are found in 
white matter (Taraboulos et al., 1992), suggesting either 
production of PrP s~ by glial cells or axonal deposition of 
neuronally produced PrP s°. The apparent lack of PrP pro- 
duction in glial cells, except for a single observation by 
Brown et al. (1990) of an astrocyte positive for PrP mRNA, 
represented a crucial gap. 
The results presented here provide unequivocal evi- 
dence that PrP mRNA is expressed in glial cells. Using 
Northern blot analysis, we have shown that PrP mRNA 
expression persists throughout adulthood in both optic 
and sciatic nerve. This expression is verified, in part, by 
in situ hybridization analysis. We would argue, from our 
Northern blot results, that the absence of an in situ signal 
in fiber tracts of adult tissue merely reflects technical diffi- 
culties of probe penetration in heavily myelinated areas 
(Schaeren-Wiemers and Gerfin-Moser, 1993). This sug- 
gests that glial cells in other brain areas, particularly white 
matter, express PrP, even though it cannot be shown di- 
rectly. 
Our findings allow us to reconcile a number of observa- 
tions. PrP c was localized by im mu nohistochemistry inneu- 
ronal cell bodies, neuropil, and some fiber tracts like the 
fimbria/fornix, whereas PrP sc accumulated most strongly 
in white matter areas such as the corpus callosum or the 
fiber tracts of the striatum (Taraboulos et al., 1992; Bend- 
helm et al., 1992). It was thought from these results that 
PrP s° was transported and deposited axonally. An alterna- 
tive view is suggested by the accumulation of PrP sc in 
astrocytes early in disease (Diedrich et al., 1991). The 
substantial PrP mRNA expression in white matter tracts 
(Figure 4C) implies that glial cells may be the primary pro- 
ducers of PrP sc and may as well be the primary target for 
prions. This hypothesis fits the observations that astro- 
cytosis is an early indicator of TSEs and is out of proportion 
to the degree of nerve cell loss and degeneration (Macken- 
zie, 1983). During the time course of TSEs, astrocytes first 
respond with a hypertrophy of endplates attached to blood 
vessels, followed by a general hypertrophy. These events 
precede other histological and clinical abnormalities in the 
course of the disease (Eklund et al., 1963; Pattison and 
Jones, 1967; Masters et al., 1984; Manuelidis et al., 1987; 
Diedrich et al., 1991). Furthermore, the sites of astroglio- 
sis coincide with the distribution of PrP sc accumulations 
(DeArmond et al., 1987). Accordingly, accumulation of the 
infectious agent was found to be indicated more accurately 
by astrogliosis or accumulation of GFAP mRNA than by 
the presence of spongiform changes (Mackenzie, 1983; 
Masters et al., 1984; Manuelidis et al., 1987). This was 
most evident in the cerebellum, where increased GFAP 
expression coincided with high concentrations of infec- 
tious agent, while no pathology was observed throughout 
the whole time course of the disease. Together, the above 
observations have led to the suggestion that astrocytosis 
is caused directly by the infectious agent rather than being 
a consequence of neuronal damage. 
More evidence for the involvement of glial cells in prion 
diseases can be deduced from cell culture experiments. 
First, treatment of mixed primary cultures with PrP sc or 
amyloidogenic peptides of PrP leads to nerve cell death, 
whereas neuronal cell lines such as PC12 or N2a neuro- 
blastoma are able to produce PrP sc without any adverse 
effect (Muller et al., 1993; Forloni et al., 1993; Rubenstein 
et al., 1984; Butler et al., 1988). Second, the neurotoxic 
effect of PrP sc on cultured neurons can be blocked by 
N-methyI-D-aspartate (NMDA) receptor antagonists (Muller 
et al., 1993). These antagonists, however, do not block 
PrP s° synthesis, indicating an indirect mechanism of neu- 
rotoxicity, which may be mediated by glial cells. An inter- 
esting parallel is the neurotoxic effect of the HIV glycopro- 
tein gp120 on cultures of cortical neurons that can also 
be blocked by NMDA receptor antagonists (Lipton et al., 
1991) and critically depends on the presence of glial cells 
(Lipton, 1992). 
Correlation of Cell Type-Specific PrP Expression 
and Scrapie Incubation Time 
Overexpression of PrP C in transgenic mice correlated with 
shorter scrapie incubation periods (Prusiner et al., 1990). 
As the level of PrP mRNA in neurons strongly increased 
during postnatal development (Figure 1), scrapie incuba- 
tion periods of adult animals would be expected to be 
shorter in adult animals than in neonatal ones. However, 
no shortening of incubation times has been observed in 
animals inoculated intracerebraily as adults, compared 
with neonatal-inoculated animals (Hotchin and Buckley, 
1977; McKinley et al., 1989; Lazarini et al., 1992). The 
expression of PrP in neurons is therefore not a limiting 
factor in incubation time. In hamsters, it has in fact been 
shown that the incubation time is shorter for neonatal than 
for weanling animals. Even though there are many possi- 
ble explanations, one should ~onsider that access to glial 
cells in prospective white matter tracts is much better prior 
to myelination. 
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Conc lus ions  
Our  results show that  glial cel ls  in young and adult  an imals  
express  PrP mRNA.  Th is  f inding prov ides the l ink between 
observat ions  impl icat ing glial cells in the product ion of 
PrP sc and the apparent ly  contrad ic tory  ev idence  of neu- 
ronal  express ion  of  PrP mRNA.  It is there fore  c lear  that 
we  will have to re formulate  our  hypotheses  of  how prion 
infect ion leads to patho log ica l  changes  in the brain and 
the subsequent  devastat ing  consequences .  
Experimental Procedures 
Synthesis of Riboprobes 
A 280 bp KpnI-BstEII fragment from a mouse PrP cDNA clone (Westa- 
way et al., 1987) was subcloned in pBluescript in both orientations 
using the pBluescript SK and KS vectors (Stratagene, La Jolla, CA). 
Antisense riboprobes (detecting PrP mRNA) and sense riboprobes 
(serving as a negative control in the in situ hybridizations) were gener- 
ated by run-off transcription from the T3 promoter of the two constructs 
in the presence of digoxigenin-UTP, according to the manufacturer's 
instructions (Boehringer Mannheim, Germany). The labeled transcripts 
were checked for strand specificity by Northern blot analysis. To en- 
sure that sense and antisense riboprobes had the same specific activ- 
ity, both probes were used to detect equal amounts of PrP DNA on 
dot blots. 
The PLP/DM-20 riboprobe corresponds to a 03 kb cDNA clone of 
PLP (Milner et al., 1985) and was synthesized in the presence of either 
digoxigenin-UTP or fluorescein-UTP. This riboprobe also detects a 
smaller splice variant of PLP that encodes the myelin protein DM-20 
(Agrawal et al., 1972; Nave et al., 1987). The MBP riboprobe was 
fluorescein-labeled and corresponds to a 0.6 kb fragment of a rat cDNA 
clone (U. P., unpublished data). The NSE riboprobe was synthesized 
from a 1.4 kb rat cDNA clone (Forss Petter et al., 1986) in the presence 
of digoxigenin-UTP. For in situ hybridizations, the NSE and PLP/DM- 
20 riboprobes were fragmented to an average size of 300 nucleotides 
by incubation with 5-10 mU/ml $7 nuclease (Boehringer Mannheim) 
for 10 rain at 37°C in 10 mM Tris-CI, 1 rnM CaCI2 (pH 8). The reaction 
was stopped by adding EDTA to a final concentration of 25 mM, and 
the enzyme was heat-inactivated at 100°C for 5 min. 
In Situ Hybridization 
Slides were organosilanized as described (Maples, 1985; Tourtellotte 
et al., 1987) with minor modifications. Briefly, slides were immersed 
in 1.5% HCI, 95% ethanol for 15 rain, rinsed in deionized water, and 
dried at 180°C. The slides were then immersed in 20/o aminopropyl 
trimethoxysilane in acetone for 5 rain, rinsed twice in acetone and 
deionized water for 1 min each, and dried at room temperature. Activa- 
tion of the silanized surface occurred during the paraformaldehyde 
fixation. 
Hamsters and rats of varying postnatal ages were anesthetized 
(using ice anesthesia [P0-P8] or ether anesthesia [older animals]) and 
decapitated, and the brains and optic nerves were dissected free. 
Tissue was embedded in Tissue-Tek medium (Miles, iN), frozen at 
-40°C in liquid nitrogen-chilled 2-methyl-butane, and stored for up 
to 1 week at -20°C. 
The in situ hybridization procedure described in this paper, using 
digoxigenin-labeled riboprobes and alkaline phosphatase (AP) immu- 
nohistochemistry, is a modification of the method described by 
Springer et al. (1991). Cryostat sections of unfixed frozen tissue (15 
p_m) were mounted on organosilanized slides, fixed with 4% paraform- 
aldehyde in PBS for 15 rain, and washed three times with PBS for 5 
rain each. The sections were then acetylated in 0.1 M triethanolamine, 
0.25% acetic anhydride for 10 rain and washed two times in PBS for 
5 rain each, followed by one wash in 2 x SSC for 5 rain. Prehybridiza- 
tion was done in 50% formamide, 5x  SSC, 2% blocking reagent 
(Boehringer Mannheim), 0.1% N-lauroylsarcosine, 0.020/0 SDS for 
3-20 hr at room temperature; hybridization was done overnight at 
70°C with digoxigenin- or fluorescein-labeled riboprobes in the prehy- 
bridization buffer described above. Probe concentrations were 30 ng/ 
ml for the labeled PrP antisense and sense transcripts and 50-100 ng/ 
ml for all other probes. For prehybridization and hybridization, sections 
were encircled with rubber cement and covered with 300-700 p.I of 
the respective solution. Prehybridization and hybridization was done 
in sealed boxes that contained Kleenex tissues soaked in 50% for- 
mamide, 5 x SSC. After hybridization, the sections were washed two 
times in 2x  SSC for 1 rain at 68°C and two times in 0.2x SSC for 
30 min each at 68°C. 
Hybridized probes were visualized with AP-coupled anti-digoxigenin 
Fab fragments or with AP-coupled antFfluorescein Fab fragments (anti- 
digoxigenin-AP and anti-fluorescein-AP; Boehringer Mannheim). Spe- 
cifically, sections were equilibrated in MAL buffer (0.15 M sodium chlo- 
ride, 0.1 M maleic acid [pH 7.5]) for 5 rain at room temperature and 
blocked for 1 hr at room temperature in MAL buffer containing 1% 
blocking reagent. The sections were then incubated for 1 hr at room 
temperature in anti-digoxigenin-AP (1:5000) or anti-fluorescein-AP 
(1:1000) in the 10/o blocking reagent/MAL buffer, followed by two 
washes for 30 rain each in MAL buffer. After equilibration in AP buffer 
(0.1 M sodium chloride, 5 mM magnesium chloride, 0.1 M Tris-CI [pH 
9.5]) for 5 min, the color reaction was performed in the dark using 300 
p.g/ml nitroblue tetrazolium (Bio-Rad) and 150 pg/ml 5-bromo-4-chloro- 
3-indolyl phosphate (Bio-Rad) in AP buffer. The reaction was stopped 
in 10 mM Tris-CI, 25 mM EDTA (pH 8.0). 
To estimate the numbers of cells expressing PrP mRNA in propor- 
tion with total cell numbers, some of the sections were counterstained 
after the in situ hybridization procedure with Hoechst 33258 dye 
(1:100; Calbiochem)for 5 rain. 
Double in situ hybridization for PrP and PLP/DM-20 mRNA detection 
was done by hybridizing the sections to digoxigenin-labeled PrP ribo- 
probes and fluorescein-labeled PLP/DM-20 riboprobes simultane- 
ously. After the detection of the PrP mRNA, the sections were sequen- 
tially immersed in distilled water, 100% ethanol, and distilled water 
again for 5 rain each. The immunological detection was then performed 
as above with anti-fluorescein-AP. The treatment of the sections with 
ethanol causes the second color reaction product to be brown, so 
that it can be distinguished from the purple color of the first reaction 
product. 
Immunofluorescence Detection of GFAP after the In Situ 
Hybridization Procedure 
For GFAP immunofluorescence detection, polyclonal rabbit anti-cow 
GFAP antibody (1:300; Dakopatts, Denmark) was added to the buffer 
containing the anti-digoxigenin-AP conjugate in the in situ hybridiza- 
tion procedure. After the development of the in situ hybridization sig- 
nals, sections were incubated in 1% blocking reagent/MAL buffer for 
30 min at room temperature. After incubation with rhodamine isothiocy- 
anate-coupled goat anti-rabbit immunoglobulin (1:100; Jackson) for 
1 hr at room temperature in the same buffer, sections were washed 
three times for 25 min in MAL buffer. Hoechst 33258 dye was used 
as described above to visualize nuclei. 
X-irradiation Treatment 
The method used to deplete the developing optic nerve of oligodendro- 
cytes is described by Colello et al. (1994). Briefly, Lewis rat pups were 
unilaterally administered a 5500 rad dose of X-rays for 5 rain at P0, 
P2, and P4. This caused myelination of the irradiated optic nerve to 
be delayed until after P14. 
Oligodendrocyte Isolation 
Lewis rats (14- to 17-day-old) were sacrificed as described for in situ 
hybridization. The brains were dissected and the cerebral hemispheres 
and the cerebellum discarded. The remaining tissue, predominantly 
brain stem, was minced and digested with 0. t % trypsin (type III, Sigma) 
and 0.01% collagenase (Worthington) for 30 rain at 37°C. After push- 
ing through 80 ~m meshes, the cell suspension was centrifuged at 
30,000 x g in 36% Percoll (Pharmacia, Sweden) in HEPES (25 raM)- 
buffered Hank's solution (pH 7.4) as described by Berti Mattera et al. 
(1984), Cells floating at a density between 1.033 and 1.047 g/ml were 
collected and examined for oligodendrocyte nrichment by galactoce- 
rebroside immunocytochemistry and by Northern blot analysis of PLP/ 
DM-20 mRNA content. 
Northern Blots 
Lewis rats were sacrificed as described for in situ hybridization. Total 
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RNA was isolated from the following rat tissues: brain stem (P14- 
P17), purified oligodendrocytes (P14-P17), optic nerve (P2, P14, and 
adult), total brain (adult), and sciatic nerve (adult). For all tissues except 
optic and sciatic nerves of adult animals, the isolation was done by 
the guanidinium thiocyanate/cesium chloride method (Sambrook et 
al., 1989) using cesium trifluoroacetate instead of cesium chloride. 
For optic and sciatic nerves of adult animals, isolation was done ac- 
cording to Chomczynski and Sacchi (1987). 
The Northern blot shown in Figure 4A was performed as described 
by Colello et al. (1994), whereas the Northern blots shown in Figures 
4B and 4C were performed as described by Moser et al. (1993). Briefly, 
500 ng of total RNA per lane (except for the bottom panel in Figure 
4B, in which 40 ng per lane was used for MBP mRNA detection) was 
separated on agarose/formaldehyde minigels, electroblotted onto Gene- 
screen membrane (DuPont/NEN), and hybridized with digoxigenin- or 
fluorescein-labeled riboprobes similar to the manufacturers instruc- 
tions (Boehringer Mannheim). Hybridized probes were detected by 
immunochemiluminescence using AMPPD substrate (Tropix) and 
Hyperfilm-ECL (Amersham). 
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